Immune mechanisms in uveitis: What can be learned from in vivo imaging?

Ophthalmology Clinics of North America

Volumn 15, Issue 3, 2002, Pages 259-270

  Becker, Matthias D ^a,b,d   Dullforce, Per A ^a,c   Martin, Tammy M ^a,c   Smith, Justine R ^a   Planck, Stephen R ^a,c   Rosenbaum, James T ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CYTOKINE; ENDOTOXIN; IMMUNOSUPPRESSIVE AGENT; MELANIN; MYELIN BASIC PROTEIN; OVALBUMIN; PHOSDUCIN; RECOVERIN; RETINA S ANTIGEN; RHODOPSIN; TACROLIMUS;

ANTIGEN PRESENTING CELL; CLINICAL FEATURE; DISEASE MODEL; EYE DISEASE; FLUORESCENCE MICROSCOPY; HUMAN; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE MIGRATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; UVEITIS; VOGT KOYANAGI SYNDROME;

EID: 0036710888     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00022-6     Document Type: Review

References (91)

1. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-6.
2. Springer T. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-14.
3. Becker MD, Adamus G, Davey MP, Rosenbaum JT. The role of T cells in autoimmune uveitis. Ocul Immunol Inflamm 2000;8:93-100.
4. Baatz H, Pleyer U, Thiel H-J, Hammer C. In vivo study of leukocyte-endothelium interaction in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1995;36:1960-7.
5. Becker MD, Nobiling R, Planck SR, Rosenbaum JT. Digital video-imaging of leukocyte migration in the iris: Intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis. J Immunol Methods 2000;240:23-37.
6. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci 1995;36:123-30.
7. Becker MD, Kruse FE, Joussen AM, Rohrschneider K, Nobiling R, Gebhard MM, et al. In vivo fluorescence microscopy of corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 1998;236:390-8.
8. Martin TM, Allada G, Becker MD, Planck S, Rosenbaum JT. Imaging of normal and inflamed conjunctival microvasculature in rats using real-time fluorescence intravital microscopy [abstract 3565]. Invest Ophthalmol Vis Sci 2000;41(4):S650.
9. Freyschuss A, Xiu RJ, Zhang J, Ying X, Diczfalusy U, Jogestrand T, et al. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler Thromb Vasc Biol 1997;17:1178-84.
10. Kimura H, Kiryu J, Nishiwaki H, Ogura Y. A new fluorescent imaging procedure in vivo for evaluation of the retinal microcirculation in rats. Curr Eye Res 1995;14:223-8.
11. Miyamoto K, Ogura Y, Hamada M, Nishiwaki H, Hiroshiba N, Honda Y. In vivo quantification of leukocyte behavior in the retina during endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1996;37:2708-15.
12. Matsuda N, Ogura Y, Nishiwaki H, Miyamoto K, Matsubara T, Kiryu J, et al. Visualization of leukocyte dynamics in the choroid with indocyanine green. Invest Ophthalmol Vis Sci 1996;37:2228-33.
13. Rosenbaum JT, Brischetto M, Crespo S, Bierwirth M, Oveson K, Planck S, et al. Simultaneous in Vivo Imaging of Leukocyte Migration - Heterogeneity Among Iris, Limbus, and Choroid Vessels. Submitted for publication.
14. Kirveskari J, Vesaluoma MH, Moilanen JA, Tervo TM, Petroll MW, Linnolahti E, et al. A novel non-invasive, in vivo technique for the quantification of leukocyte rolling and extravasation at sites of inflammation in human patients. Nat Med 2001;7:376-9.
15. Paques M, Boval B, Richard S, Tadayoni R, Massin P, Mundler O, et al. Evaluation of fluorescein-labeled autologous leukocytes for examination of retinal circulation in humans. Curr Eye Res 2000;21:560-5.
16. Becker MD, Crespo S, Martin TM, Planck SR, Naramura M, Rosenbaum JT, Intraocular in vivo imaging of activated T-lymphocytes expressing green-fluorescent protein after stimulation with endotoxin. Graefes Arch Clin Exp Ophthalmol 2001;239:609-12.
17. Hossain P, Liversidge J, Cree MJ, Manivannan A, Vieira P, Sharp PF, et al. In vivo cell tracking by scanning laser ophthalmoscopy: Quantification of leukocyte kinetics. Invest Ophthalmol Vis Sci 1998;39:1879-87.
18. Suing CM, Becker MD, Crespo S, Adamus G, Planck SR, Rosenbaum JT, et al. In vivo successive examination of an ocular inflammatory immune response mediated by antigen specific T cells in the EAE model of uveitis [abstract 4902]. Invest Ophthalmol Vis Sci 2001;42(4):S912.
19. Becker MD, Crespo S, Fleischmann RJ, Martin TM, Planck SR, Rosenbaum JT. Time lapse recording as a tool to detect and measure movements of infiltrating or resident cells in mouse iris during experimental models of uveitis [abstract 4900]. Invest Ophthalmol Vis Sci 2001;42(4):S912.
20. Dullforce PA, Crespo SM, Becker MD, Planck SR, Rosenbaum JT. Investigation of cells by intravital microscopy in an antigen driven model of anterior uveitis [abstract 4901]. Invest Ophthalmol Vis Sci 2001;42(4):S912.
21. Crespo SM, Becker MD, Martin TM, Fleischmann RJ, Planck SR, Rosenbaum JT. In vivo observation of antigen uptake by subsets of antigen presenting cells in the mouse iris [abstract 4899]. Invest Ophthalmol Vis Sci 2001;42(4):S912.
22. von Andrian UH, M'Rini C. In situ analysis of lymphocyte migration to lymph nodes. Cell Adhes Commun 1998;6:85-96.
23. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, Gunn MD, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000;191:61-75.
24. Stockton BM, Cheng GY, Manjunath N, Ardman B, von Andrian UH. Negative regulation of T cell homing by CD43. Immunity 1998;8:373-81.
25. Hokari R, Miura S, Fujimori H, Koseki S, Tsuzuki Y, Kimura H, et al. Altered migration of gut-derived T lymphocytes after activation with concanavalin A. Am J Physiol 1999;277:G763-72.
26. Shigematsu T, Specian RD, Wolf RE, Grisham MB, Granger DN. MAdCAM mediates lymphocyte-endothelial cell adhesion in a murine model of chronic colitis. Am J Physiol 2001;281:G1309-15.
27. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al. The immunological synapse: A molecular machine controlling T cell activation. Science 1999;285:221-7.
28. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19:395-404.
29. Solomon SD, Cunningham ETJ. Use of corticosteroids and noncorticosteroid immunosuppressive agents in patients with uveitis. Comprehensive Ophthalmology Update. 2001;1:273-86.
30. Rajasingh J, Singh VK, Singh V, Sharma K, Agarwal SS. Cellular immune response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in idiopathic human uveitis. Indian J Med Res 1996;103:222-6.
31. de Smet MD, Yamamoto JH, Mochizuki M, Gery I, Singh VK, Shinohara T, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990;110:135-42.
32. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol 1993;77:584-9.
33. Wildner G, Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: A clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 1994;24:2579-85.
34. Marker-Hermann E, Meyer zum Buschenfelde KH, Wildner G. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum 1997;40:2047-54.
35. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2001;42:2004-9.
36. Okumura A, Mochizuki M. Endotoxin-induced uveitis in rats: Morphological and biochemical study. Jpn J Ophthalmol 1988;32:457-65.
37. McMenamin PG, Crewe J. Endotoxin-induced uveitis: Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body. Invest Ophthalmol Vis Sci 1995;36:1949-59.
38. Bhattacherjee P, Williams RN, Eakins KE. An evaluation of ocular inflammation following the injection of bacterial endotoxin into the rat foot pad. Invest Ophthalmol Vis Sci 1983;24:196-202.
39. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980;286:611-3.
40. Kogiso M, Tanouchi Y, Mimura Y, Nagasawa H, Himeno K. Endotoxin-induced uveitis in mice. I. Induction of uveitis and role of T lymphocytes. Jpn J Ophthalmol 1992;36:281-90.
41. Whitcup SM, Pleyer U, Lai JC, Lutz S, Mochizuki M, Chan CC. Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. Ocul Immunol Inflamm 1998;6:51-6.
42. Li Q, Peng B, Whitcup SM, Jang SU, Chan CC. En dotoxin-induced uveitis in the mouse: Susceptibility and genetic control. Exp Eye Res 1995;61:629-32.
43. Brito BE, O'Rourke LM, Pan Y, Huang X, Park JM, Zamora D, et al. Murine endotoxin-induced uveitis, but not immune complex-induced uveitis, is dependent on the IL-8 receptor homologue. Curr Eye Res 1999;19:76-85.
44. Rosenbaum JT, Han YB, Park JM, Kennedy M, Planck SR. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: Studies in cytokine receptor deficient mice. J Rheumatol 1998;25:2408-16.
45. Rosenbaum JT, Kievit P, Han YB, Park JM, Planck SR. Interleukin-6 does not mediate endotoxin-induced uveitis in mice: Studies in gene deletion animals. Invest Ophthalmol Vis Sci 1998;39:64-9.
46. Becker MD, O'Rourke LM, Blackman WS, Planck SR, Rosenbaum JT. Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice. Invest Ophthalmol Vis Sci 2000;41:1812-7.
47. Miyamoto K, Ogura Y, Hamada M, Nishiwaki H, Hiroshiba N, Tsujikawa A, et al. In vivo neutralization of P-selectin inhibits leukocyte-endothelial interactions in retinal microcirculation during ocular inflammation, Microvasc Res 1998;55:230-40.
48. Yamashiro K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Miyamoto K, et al. Inhibitory effects of antithrombin III against leukocyte rolling and infiltration during endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2001;42:1553-60.
49. Rosenbaum JT, Boney RS. Efficacy of antibodies to adhesion molecules, CD11a or CD18, in rabbit models of uveitis. Curr Eye Res 1993;12:827-31.
50. Whitcup SM, DeBarge LR, Rosen H, Nussenblatt RB, Chan CC. Monoclonal antibody against CD11b/CD18 inhibits endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1993;34:673-81.
51. Planck SR, Han YB, Park JM, O'Rourke L, Gutierrez-Ramos JC, Rosenbaum JT. The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitis. Curr Eye Res 1998;17:941-6.
52. Becker MD, Garman K, Whitcup SM, Planck SR, Rosenbaum JT. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to icam-1 and Ifa-1 in murine endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 2001;42:2563-6.
53. Broekhuyse RM, Kuhlmann ED. Experimental autoimmune anterior uveitis: The preparation of uveitogenic ocular melanin. Invest Ophthalmol Vis Sci 1993;34:698-700.
54. Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ. Induction of experimental autoimmune anterior uveitis by a self-antigen: Melanin complex without adjuvant. Invest Ophthalmol Vis Sci 1997;38:2171-5.
55. Smith JR, Hart PH, Parish CR, Standfield SD, Coster DJ, Williams KA. Experimental melanin-induced uveitis in the Fischer 344 rat is inhibited by anti-CD4 monoclonal antibody, but not by mannose-6-phosphate. Clin Exp Immunol 1999;115:64-71.
56. Broekhuyse R, Winkens H, Kuhlmann E. Multiple recurrences in melanin-protein-induced uveitis in the rat. Ocul Immunol Inflamm 1995;3:149-55.
57. Dick AD, Siepmann K, Dees C, Duncan L, Broderick C, Liversidge J, et al. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Invest Ophthalmol Vis Sci 1999;40:2258-67.
58. Chan CC, Hikita N, Dastgheib K, Whitcup SM, Gery I, Nussenblatt RB. Experimental melanin-protein-induced uveitis in the Lewis rat: Immunopathologic processes. Ophthalmology 1994;101:1275-80.
59. Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uvoitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp Eye Res 1992;55:401-11.
60. Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1995;14:703-10.
61. Woon MD, Kaplan HJ, Bora NS. Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1998;17:955-61.
62. + T cells occurs in experimental autoimmune anterior uveitis (EAAU). Clin Exp Immunol 1999;118:357-63.
63. Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SJ, Williams KA. Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 2000;84:205-11.
64. Broekhuyse RM, Huitinga I, Kuhlmann ED, Rooijen NV, Winkens HJ. Differential effect of macrophage depletion on two forms of experimental uveitis evoked by pigment epithelial membrane protein (EAPU), and by melanin-protein (EMIU). Exp Eye Res 1997;65:841-8.
65. Shao H, Woon MD, Nakamura S, Sohn JH, Morton PA, Bora NS, et al. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2001;42:2016-21.
66. Thurau SR, Wildner G, Reiter C, Riethmuller G, Lund OE. Treatment of endogenous uveitis with anti-CD4 monoclonal antibody: First report. German J Ophthalmol 1994;3:409-13.
67. Smith JR, O'Rourke LM, Becker MD, Cao M, Williams KA, Planck SR, et al. Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis. Curr Eye Res 2000;21:906-12.
68. +) T lymphocytes in vivo. J Immunol 1999;162:766-73.
69. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 1996;157:2262-71.
70. Forrester JV, Liversidge J, Dua HS, Dick A, Harper F, McMenamin PG. Experimental autoimmune uveoretinitis: A model system for immunointervention: A review. Curr Eye Res 1992;11:33-40.
71. Caspi RR. Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol 1992;4:321-30.
72. Nussenblatt RB, Gery I. Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. J Autoimmun 1996;9:575-85.
73. Okada AA, Goto H, Mizusawa T, Morimoto K, Ebihara Y, Usui M. Angiography of experimental autoimmune uveoretinitis with ultrastructural correlation. Graefes Arch Clin Exp Ophthalmol 1998;236:865-72.
74. Howe LJ, Stanford MR, Whiston R, Dewhirst R, Marshall J. Angiographic abnormalities of experimental autoimmune uveoretinitis. Curr Eye Res 1996;15:1149-55.
75. Masaoka N, Takahashi A, Fukushima A. Comparison between histopathologic findings and indocyanine green angiographic findings in Lewis rats with experimental autoimmune uveoretinitis. Jpn J Ophthalmol 2000;44:620-6.
76. Hamada M, Ogura Y, Miyamoto K, Nishiwaki H, Hiroshiba N, Honda Y. Retinal leukocyte behavior in experimental autoimmune uveoretinitis of rats. Exp Eye Res 1997;65:445-50.
77. Pamaby-Price A, Stanford MR, Biggerstaff J, Howe L, Whiston RA, Marshall J, et al. Leukocyte trafficking in experimental autoimmune uveitis in vivo. J Leukoc Biol 1998;64:434-40.
78. Bullington S, Waksman B. Uveitis in rabbits with experimental allergic encephalomyelitis. Arch Ophthalmol 1958;59:435-45.
79. Hayreh SS, Massanari RM, Yamada T, Hayreh SM. Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations. Invest Ophthalmol Vis Sci 1981;21:256-69.
80. Hayreh SS. Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations. Invest Ophthalmol Vis Sci 1981;21:270-81.
81. Adamus G, Amundson D, Vainiene M, Ariail K, Machnicki M, Weinberg A, et al. Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res 1996;44:513-8.
82. Verhagen C, Mor F, Cohen IR. T cell immunity to myelin basic protein induces anterior uveitis in Lewis rats. J Neuroimmunol 1994;53:65-71.
83. Fritz RB, Chou CH, McFarlin DE. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: Localization of a second encephalitogenic determinant. J Immunol 1983;130:191-4.
84. Constantinescu CS, Lavi E. Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res 2000;20:71-6.
85. Huhtala A. Origin of myelinated nerves in the rat iris. Exp Eye Res 1976;22:259-65.
86. Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1998;39:754-62.
87. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye 1997;11:183-93.
88. Werr J, Xie X, Hedqvist P, Ruoslahti E, Lindbom L. Beta(l) integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. J Exp Med 1998;187:2091-6.
89. Werr J, Johansson J, Eriksson EE, Hedqvist P, Ruoslahti E, Lindbom L. Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood 2000;95:1804-9.
90. Hickey MJ, Forster M, Mitchell D, Kaur J, De Caigny C, Kubes P. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. J Immunol 2000;165:7164-70.
91. Naramura M, Hu RJ, Gu H. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity 1998;9:209-16.